Clough Capital Partners’s Dynavax Technologies DVAX Stock Holding History

Clough Capital Partners’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,500	Closed	-$278K	–	176
2016 Q3	$278K	Sell	26,500 -217,384	-89%	-$3.12M	0.01%	160
2016 Q2	$3.56M	Sell	243,884 -159,599	-40%	-$2.73M	0.19%	117
2016 Q1	$7.76M	Buy	403,483 +41,100	+11%	+$831K	0.37%	84
2015 Q4	$8.76M	Buy	362,383 +76,525	+27%	+$1.92M	0.41%	77
2015 Q3	$7.01M	Sell	285,858 -238,050	-45%	-$6.74M	0.3%	82
2015 Q2	$12.3M	Sell	523,908 -292,400	-36%	-$6.37M	0.47%	79
2015 Q1	$18.3M	Sell	816,308 -151,500	-16%	-$2.9M	0.61%	72
2014 Q4	$16.3M	Buy	967,808 +529,648	+121%	+$8.07M	0.59%	68
2014 Q3	$6.27M	Buy	438,160 +170,090	+63%	+$2.45M	0.23%	107
2014 Q2	$4.29M	Buy	+268,070	New	+$4.04M	0.14%	137

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Clough Capital Partners's DVAX Position: Q4 2016 in Review

Clough Capital Partners sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 26,500 shares — an estimated $278K sold.

Clough Capital Partners first reported a position in DVAX in Q2 2014 and held it in 10 quarters. The position peaked at $18.3M in Q1 2015. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

Clough Capital Partners reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
Clough Capital Partners sold 26,500 Dynavax Technologies shares in Q4 2016, an estimated $278K.
Clough Capital Partners first reported a position in Dynavax Technologies in Q2 2014 and held it in 10 quarters.
Clough Capital Partners's Dynavax Technologies position peaked at $18.3M in Q1 2015.
111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Clough Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.